These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9067408)

  • 1. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.
    Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Kurimoto M
    Cancer Immunol Immunother; 1997 Jan; 43(6):361-7. PubMed ID: 9067408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
    Okamoto M; Gohda H; Ohe G; Yoshida H; Matsuno T; Saito M; Sato M
    J Immunother; 2000 Jan; 23(1):94-103. PubMed ID: 10687142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice.
    Akamatsu S; Arai N; Hanaya T; Arai S; Tanimoto T; Fujii M; Kohno K; Micallef MJ; Ikeda M; Kurimoto M
    J Immunother; 2002; 25 Suppl 1():S28-34. PubMed ID: 12048348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
    Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
    Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432.
    Saito M; Nanjo M; Aonuma E; Noda T; Nakadate I; Ebina T; Ishida N
    Int J Cancer; 1984 Feb; 33(2):271-6. PubMed ID: 6420351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with irritant and recombinant interleukin 2 in the peritoneal cavity for evoking effective anti-tumor activity: generation of lymphokine-activated killer cells and tumor-specific killer cells.
    Uchida H; Taniguchi K; Nomoto K
    Jpn J Cancer Res; 1990 Apr; 81(4):416-24. PubMed ID: 2114394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of in vitro interleukin 10 production after in vivo administration of interleukin 18 is activated macrophage-dependent and is probably not involved in the antitumor effects of interleukin 18.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Ikegami H; Kurimoto M
    Anticancer Res; 1998; 18(6A):4267-74. PubMed ID: 9891477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs.
    Rosenthal FM; Cronin K; Bannerji R; Golde DW; Gansbacher B
    Blood; 1994 Mar; 83(5):1289-98. PubMed ID: 8118032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors.
    Fujioka T; Ishikura K; Tanji S; Okamoto T; Koike H; Aoki H; Ohhori T; Kubo T
    Int J Immunopharmacol; 1990; 12(4):419-26. PubMed ID: 2391188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.
    Palladino MA; Shalaby MR; Kramer SM; Ferraiolo BL; Baughman RA; Deleo AB; Crase D; Marafino B; Aggarwal BB; Figari IS
    J Immunol; 1987 Jun; 138(11):4023-32. PubMed ID: 3295044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous exposure to interleukin-18 and interleukin-10 in vitro synergistically augments murine spleen natural killer cell activity.
    Micallef MJ; Tanimoto T; Torigoe K; Nishida Y; Kohno K; Ikegami H; Kurimoto M
    Cancer Immunol Immunother; 1999; 48(2-3):109-17. PubMed ID: 10414464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inoculation of human interleukin-17 gene-transfected Meth-A fibrosarcoma cells induces T cell-dependent tumor-specific immunity in mice.
    Hirahara N; Nio Y; Sasaki S; Minari Y; Takamura M; Iguchi C; Dong M; Yamasawa K; Tamura K
    Oncology; 2001; 61(1):79-89. PubMed ID: 11474253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
    Hunter CA; Subauste CS; Van Cleave VH; Remington JS
    Infect Immun; 1994 Jul; 62(7):2818-24. PubMed ID: 7911785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor response independent of functional B or T lymphocytes induced by the local and sustained release of interleukin-2 by the tumor cells.
    Alosco T; Croy BA; Gansbacher B; Wang HQ; Rao U; Bankert R
    Cancer Immunol Immunother; 1993 Jun; 36(6):364-72. PubMed ID: 8500109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.